186 related articles for article (PubMed ID: 10383531)
1. A double-blind, randomized, multicentre, crossover study to prove equivalence of pancreatin minimicrospheres versus microspheres in exocrine pancreatic insufficiency.
Halm U; Löser C; Löhr M; Katschinski M; Mössner J
Aliment Pharmacol Ther; 1999 Jul; 13(7):951-7. PubMed ID: 10383531
[TBL] [Abstract][Full Text] [Related]
2. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study.
Thorat V; Reddy N; Bhatia S; Bapaye A; Rajkumar JS; Kini DD; Kalla MM; Ramesh H
Aliment Pharmacol Ther; 2012 Sep; 36(5):426-36. PubMed ID: 22762290
[TBL] [Abstract][Full Text] [Related]
3. Randomised clinical trial: a 1-week, double-blind, placebo-controlled study of pancreatin 25 000 Ph. Eur. minimicrospheres (Creon 25000 MMS) for pancreatic exocrine insufficiency after pancreatic surgery, with a 1-year open-label extension.
Seiler CM; Izbicki J; Varga-Szabó L; Czakó L; Fiók J; Sperti C; Lerch MM; Pezzilli R; Vasileva G; Pap A; Varga M; Friess H
Aliment Pharmacol Ther; 2013 Apr; 37(7):691-702. PubMed ID: 23383603
[TBL] [Abstract][Full Text] [Related]
4. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis.
O'Keefe SJ; Cariem AK; Levy M
J Clin Gastroenterol; 2001 Apr; 32(4):319-23. PubMed ID: 11276275
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
[TBL] [Abstract][Full Text] [Related]
6. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.
Ramesh H; Reddy N; Bhatia S; Rajkumar JS; Bapaye A; Kini D; Kalla M; Thorat V
Pancreatology; 2013; 13(2):133-9. PubMed ID: 23561971
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
[TBL] [Abstract][Full Text] [Related]
8. Optimal size range for enteric-coated pancreatin preparations.
Lederer PC
Pancreas; 2011 Mar; 40(2):310-1. PubMed ID: 21311309
[No Abstract] [Full Text] [Related]
9. Two enteric coated microspheres in cystic fibrosis.
Williams J; MacDonald A; Weller PH; Fields J; Pandov H
Arch Dis Child; 1990 Jun; 65(6):594-7. PubMed ID: 2198848
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
[TBL] [Abstract][Full Text] [Related]
11. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
[TBL] [Abstract][Full Text] [Related]
12. Creon 10,000 Minimicrospheres vs. Creon 8,000 microspheres--an open randomised crossover preference study.
Patchell CJ; Desai M; Weller PH; Macdonald A; Smyth RL; Bush A; Gilbody JS; Duff SA
J Cyst Fibros; 2002 Dec; 1(4):287-91. PubMed ID: 15463829
[TBL] [Abstract][Full Text] [Related]
13. Lack of dose-response with Pancrease MT for the treatment of exocrine pancreatic insufficiency in adults.
Opekun AR; Sutton FM; Graham DY
Aliment Pharmacol Ther; 1997 Oct; 11(5):981-6. PubMed ID: 9354210
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
Dutta SK; Rubin J; Harvey J
Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
[TBL] [Abstract][Full Text] [Related]
15. Gastric transit and pharmacodynamics of a two-millimeter enteric-coated pancreatin microsphere preparation in patients with chronic pancreatitis.
Bruno MJ; Borm JJ; Hoek FJ; Delzenne B; Hofmann AF; de Goeij JJ; van Royen EA; van Leeuwen DJ; Tytgat GN
Dig Dis Sci; 1998 Jan; 43(1):203-13. PubMed ID: 9508526
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of enteric-coated pancreatin microsphere therapy after conventional and pylorus-preserving pancreatoduodenectomy.
Bruno MJ; Borm JJ; Hoek FJ; Delzenne B; Hofmann AF; de Goeij JJ; van Royen EA; van Gulik TM; de Wit LT; Gouma DJ; van Leeuwen DJ; Tytgat GN
Br J Surg; 1997 Jul; 84(7):952-6. PubMed ID: 9240133
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis to investigate the effect of concomitant use of gastric acid-suppressing drugs on the efficacy and safety of pancrelipase/pancreatin (CREON®) in patients with pancreatic exocrine insufficiency.
Sander-Struckmeier S; Beckmann K; Janssen-van Solingen G; Pollack P
Pancreas; 2013 Aug; 42(6):983-9. PubMed ID: 23587850
[TBL] [Abstract][Full Text] [Related]
18. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region.
Bruno MJ; Haverkort EB; Tijssen GP; Tytgat GN; van Leeuwen DJ
Gut; 1998 Jan; 42(1):92-6. PubMed ID: 9505892
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
[TBL] [Abstract][Full Text] [Related]
20. Properties of different pancreatin preparations used in pancreatic exocrine insufficiency.
Löhr JM; Hummel FM; Pirilis KT; Steinkamp G; Körner A; Henniges F
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1024-31. PubMed ID: 19352190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
